These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8540754)

  • 1. Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV.
    Clanton DJ; Buckheit RW; Terpening SJ; Kiser R; Mongelli N; Borgia AL; Schultz R; Narayanan V; Bader JP; Rice WG
    Antiviral Res; 1995 Aug; 27(4):335-54. PubMed ID: 8540754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application.
    Howard OM; Oppenheim JJ; Hollingshead MG; Covey JM; Bigelow J; McCormack JJ; Buckheit RW; Clanton DJ; Turpin JA; Rice WG
    J Med Chem; 1998 Jun; 41(13):2184-93. PubMed ID: 9632350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors.
    Buckheit RW; Fliakas-Boltz V; Decker WD; Roberson JL; Pyle CA; White EL; Bowdon BJ; McMahon JB; Boyd MR; Bader JP
    Antiviral Res; 1994 Sep; 25(1):43-56. PubMed ID: 7529014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule inhibitor of HIV-1 cell fusion blocks chemokine receptor-mediated function.
    Howard OM; Korte T; Tarasova NI; Grimm M; Turpin JA; Rice WG; Michejda CJ; Blumenthal R; Oppenheim JJ
    J Leukoc Biol; 1998 Jul; 64(1):6-13. PubMed ID: 9665268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Joao HC; Witvrouw M; De Vreese K; Pauwels R; De Clercq E
    J Med Chem; 1996 Jan; 39(1):109-19. PubMed ID: 8568797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of action.
    Clanton DJ; Moran RA; McMahon JB; Weislow OS; Buckheit RW; Hollingshead MG; Ciminale V; Felber BK; Pavlakis GN; Bader JP
    J Acquir Immune Defic Syndr (1988); 1992; 5(8):771-81. PubMed ID: 1517963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
    Chong H; Zhu Y; Yu D; He Y
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Struyf S; Witvrouw M; Schols D; De Clercq E
    J Med Chem; 1999 Sep; 42(19):3971-81. PubMed ID: 10508445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of human immunodeficiency virus by MDL 101028, a novel sulphonic acid polymer.
    Taylor DL; Brennan TM; Bridges CG; Mullins MJ; Tyms AS; Jackson R; Cardin AD
    Antiviral Res; 1995 Oct; 28(2):159-73. PubMed ID: 8585769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral activity of three pyrazole analogues of distamycin A.
    Ding L; Grehn L; De Clercq E; Andrei G; Snoeck R; Balzarini J; Fransson B; Ragnarsson U
    Acta Chem Scand (Cph); 1994 Jun; 48(6):498-505. PubMed ID: 8060726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.
    Leydet A; Moullet C; Roque JP; Witvrouw M; Pannecouque C; Andrei G; Snoeck R; Neyts J; Schols D; De Clercq E
    J Med Chem; 1998 Dec; 41(25):4927-32. PubMed ID: 9836609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
    Wild CT; Shugars DC; Greenwell TK; McDanal CB; Matthews TJ
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9770-4. PubMed ID: 7937889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro.
    Hayashi S; Norbeck DW; Rosenbrook W; Fine RL; Matsukura M; Plattner JJ; Broder S; Mitsuya H
    Antimicrob Agents Chemother; 1990 Feb; 34(2):287-94. PubMed ID: 2327778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker.
    Bridger GJ; Skerlj RT; Thornton D; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Yamamoto N; De Vreese K; Pauwels R
    J Med Chem; 1995 Jan; 38(2):366-78. PubMed ID: 7830280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
    Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assessment of compounds for anti-HIV activity.
    Patience C; Moore J; Boyd M
    Mol Biotechnol; 1994 Feb; 1(1):49-58. PubMed ID: 7532100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
    Ichimura H; Levy JA
    Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
    Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
    Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.